Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $164.53 million. The enterprise value is $178.61 million.
Important Dates
The next estimated earnings date is Thursday, March 12, 2026, before market open.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 41.03 million shares outstanding. The number of shares has increased by 15.78% in one year.
| Current Share Class | 41.03M |
| Shares Outstanding | 41.03M |
| Shares Change (YoY) | +15.78% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 13.41% |
| Owned by Institutions (%) | 22.21% |
| Float | 28.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.36 |
| Forward PS | 2.97 |
| PB Ratio | 25.93 |
| P/TBV Ratio | 28.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.44, with a Debt / Equity ratio of 6.45.
| Current Ratio | 4.44 |
| Quick Ratio | 3.47 |
| Debt / Equity | 6.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.63 |
Financial Efficiency
Return on equity (ROE) is -168.13% and return on invested capital (ROIC) is -12.46%.
| Return on Equity (ROE) | -168.13% |
| Return on Assets (ROA) | -10.06% |
| Return on Invested Capital (ROIC) | -12.46% |
| Return on Capital Employed (ROCE) | -20.49% |
| Weighted Average Cost of Capital (WACC) | 12.49% |
| Revenue Per Employee | $217,736 |
| Profits Per Employee | -$66,091 |
| Employee Count | 220 |
| Asset Turnover | 0.81 |
| Inventory Turnover | 1.97 |
Taxes
In the past 12 months, Apyx Medical has paid $265,000 in taxes.
| Income Tax | 265,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +182.39% in the last 52 weeks. The beta is 1.53, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.53 |
| 52-Week Price Change | +182.39% |
| 50-Day Moving Average | 3.82 |
| 200-Day Moving Average | 2.53 |
| Relative Strength Index (RSI) | 56.30 |
| Average Volume (20 Days) | 134,518 |
Short Selling Information
The latest short interest is 111,929, so 0.27% of the outstanding shares have been sold short.
| Short Interest | 111,929 |
| Short Previous Month | 111,685 |
| Short % of Shares Out | 0.27% |
| Short % of Float | 0.39% |
| Short Ratio (days to cover) | 1.89 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $47.90 million and -$14.54 million in losses. Loss per share was -$0.36.
| Revenue | 47.90M |
| Gross Profit | 30.01M |
| Operating Income | -9.51M |
| Pretax Income | -14.26M |
| Net Income | -14.54M |
| EBITDA | -8.93M |
| EBIT | -9.51M |
| Loss Per Share | -$0.36 |
Full Income StatementBalance Sheet
The company has $25.14 million in cash and $39.21 million in debt, with a net cash position of -$14.08 million or -$0.34 per share.
| Cash & Cash Equivalents | 25.14M |
| Total Debt | 39.21M |
| Net Cash | -14.08M |
| Net Cash Per Share | -$0.34 |
| Equity (Book Value) | 6.08M |
| Book Value Per Share | 0.15 |
| Working Capital | 37.81M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.41 million and capital expenditures -$1.08 million, giving a free cash flow of -$9.49 million.
| Operating Cash Flow | -8.41M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -9.49M |
| FCF Per Share | -$0.23 |
Full Cash Flow StatementMargins
Gross margin is 62.65%, with operating and profit margins of -19.84% and -30.35%.
| Gross Margin | 62.65% |
| Operating Margin | -19.84% |
| Pretax Margin | -29.77% |
| Profit Margin | -30.35% |
| EBITDA Margin | -18.64% |
| EBIT Margin | -19.84% |
| FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.78% |
| Shareholder Yield | -15.78% |
| Earnings Yield | -8.84% |
| FCF Yield | -5.77% |
Analyst Forecast
The average price target for Apyx Medical is $7.00, which is 74.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 74.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 39.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Apyx Medical has an Altman Z-Score of -0.37 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.37 |
| Piotroski F-Score | 3 |
